New Gene Therapy Silences Pain Without Opioid Risk

Scientists have developed the first brain-targeted gene therapy that stops chronic pain without addiction risk, offering hope to 50 million Americans.

Early tests show it works like morphine but skips the dangerous side effects that fuel the opioid crisis.